# Charles River Laboratories

Type: Company (CRL)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/charles-river-laboratories
Canonical HTML page: https://gethealthbrief.com/entity/charles-river-laboratories

## Recent coverage (1 stories)

### Biotech funding recovery could lift CRO spending by 40%+ for small biotechs
2026-06-19 02:34:06 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Morgan Stanley’s upgrade of Charles River and downgrade of IQVIA signal a shift in healthcare R&D outsourcing. CROs with deep ties to small biotech stands to gain as venture funding rebounds, potentially accelerating drug development timelines and altering cost structures for health systems.
Full story: https://gethealthbrief.com/story/morgan-stanley-cro-call-healthcare-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.